Compare OMDA & PTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMDA | PTA |
|---|---|---|
| Founded | 2011 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2025 | N/A |
| Metric | OMDA | PTA |
|---|---|---|
| Price | $23.89 | $18.38 |
| Analyst Decision | Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $21.73 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 121.8K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.31% |
| EPS Growth | ★ 94.27 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $260,210,000.00 | N/A |
| Revenue This Year | $24.96 | N/A |
| Revenue Next Year | $20.08 | N/A |
| P/E Ratio | $592.75 | ★ N/A |
| Revenue Growth | ★ 53.24 | N/A |
| 52 Week Low | $10.28 | $18.13 |
| 52 Week High | $26.92 | $20.92 |
| Indicator | OMDA | PTA |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 29.91 |
| Support Level | $14.39 | $18.13 |
| Resistance Level | $24.80 | $19.61 |
| Average True Range (ATR) | 1.17 | 0.23 |
| MACD | 0.12 | -0.04 |
| Stochastic Oscillator | 81.55 | 15.61 |
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
COHEN & STEERS TAX-ADV PRD SEC AND INC is a non-diversified, closed-end management statutory trust. Its main investment objective is high current income, and the Fund's secondary investment objective is capital appreciation.